Christoph Kalthoff holds a PhD in Biochemestry from 2003 obtained from the University of Hannover.
Dr. Kalthoff joined Novo Nordisk Pharmatech in 2023 as R&D Director where he is in charge of the research portfolio as well as the development of new products.
Dr Kalthoff joined Novo Nordisk A/S in 2006 where he has headed up different scientific and management positions – latest the LabDroid Department in Research & Early Development.
Dr. Kalthoff is a German national, born in 1973.
Scale-up production, optimise processes, and increase cellular products yields with our Recombinant Insulin that’s approved by regulatory bodies worldwide.
Explore our collection of materials and case studies about Insulin Human AF and see how it improves cell culture and boosts protein production.
Discover webinars, videos and whitepapers showcasing the broad antimicrobial effects of BKC against bacteria, yeast, mold, and enveloped viruses.
Københavnsvej 216
4600 Køge,
Denmark
+45 5667 1000
[email protected]
CVR-no. 13246149
